Chad W. Souvignier, Ph.D
Vice President
Souvignier conducts the scientific and business analysis of early-stage biomedical investment opportunities for RCT and also manages a portfolio of projects and investments for RCT. His areas of focus includes life science tools and therapeutics.
Professional Experience
- Research Corporation Technologies
Vice President, 2015–present
Managing Director, 2008-2014
Director, 2006–2007
Associate, 2004–2005
Senior Analyst, 2003 - Guilford Pharmaceuticals
Manager, International Marketing, 2001–2003
Business Analyst, 2000-2001 - Proctor & Gamble
Product Development Intern, Corporate Research Division, Summer 1999
Board Membership
- Seqwell, Inc
- Biolog, Inc.
- Halo Labs, Inc.
- TD2
Past Board Membership
- Esperance Pharmaceuticals, Inc.
- Jenrin Discovery Inc.
- Calosyn Pharmaceuticals Inc.
Education
- University of Arizona
M.B.A., Eller Graduate School of Management
Ph.D., Materials Science and Engineering - University of Akron
M.S., Polymer Science - University of Wisconsin, Eau Claire
B.S., Chemistry
Contact
Assistant: Andrea Lance
(520) 748-4468
General: (520) 748-4400